UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

                                   (Mark One)

|X|   QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
      OF 1934

                  For the quarterly period ended March 31, 2007

|_|   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT


               For the transition period from ______ to __________

                        Commission File Number : 0-27569

                             NATURAL NUTRITION, INC.
                             -----------------------
        (Exact name of small business issuer as specified in its charter)

              Nevada                                      65-0847995
---------------------------------------  ---------------------------------------
(State or other jurisdiction of                (IRS Employer Identification No.)
  incorporation or organization)

                       109 North Post Oak Lane, Suite 422
                                Houston, TX 77024
--------------------------------------------------------------------------------
                    (Address of principal executive offices)

                                 (713) 621-2737
--------------------------------------------------------------------------------
                           (Issuer's telephone number)

                      (Formerly CSI Business Finance, Inc.)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes |X|  No |_|

Indicate by check whether the  registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Yes |_|  No |X|

The  number of shares  outstanding  of our  common  stock at April 30,  2007 was
12,737,983.

Transitional Small Business Disclosure Format (check one):   Yes:      No:   X

                                      - 1 -
<PAGE>

                             NATURAL NUTRITION, INC.
                      (Formerly CSI Business Finance, Inc.)
                                   FORM 10-QSB

                                      INDEX

                                                                           Page
                                                                          Number
                                                                          ------

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed Consolidated Balance Sheet as of March 31, 2007 (Unaudited)          3
Condensed Consolidated Statements of Operations for the three months
ended March 31, 2007 and 2006 (Unaudited)                                      4
Condensed Consolidated Statements of Cash Flows for the three months
ended March 31, 2007 and 2006 (Unaudited)                                      5
Notes to Condensed Consolidated Financial Statements (Unaudited)            6-10
Item 2. Management's Discussion and Analysis or Plan of Operation          10-13
Item 3. Controls and Procedures                                            13-14

PART II - OTHER INFORMATION
Item 1. Legal Proceedings                                                    15
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds          15
Item 3. Defaults Upon Senior Securities                                      15
Item 4. Submission of Matters to a Vote of Security Holders                  15
Item 5. Other Information                                                    15
Item 6. Exhibits                                                             15
SIGNATURES                                                                   16

<PAGE>

PART I -FINANCIAL INFORMATION

Item 1.  Financial Statements

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                      (Formerly CSI Business Finance, Inc.)
                      CONDENSED CONSOLIDATED BALANCE SHEET
                                 March 31, 2007
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                ASSETS
<S>                                                                                <C>
CURRENT ASSETS
    Cash                                                                           $     89,540
    Notes receivable                                                                  1,978,142
    Investment in marketable securities                                                 702,782
    Due from affiliate                                                                  113,244
    Prepaids, accrued interest and other accounts receivable                            112,737
                                                                                   ------------
    Total current assets                                                              2,996,445
                                                                                   ------------

NONCURRENT ASSETS
    Investments                                                                       9,462,958
    Fixed assets, net                                                                     4,292
                                                                                   ------------
Total noncurrent assets                                                               9,467,250
                                                                                   ------------
TOTAL ASSETS                                                                       $ 12,463,695
                                                                                   ============
                                 LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES
    Accounts payable, accrued liabilities and other current liabilities            $    260,273
                                                                                   ------------
    Total current liabilities                                                           260,273

NONCURRENT LIABILITIES
    Debenture payable--net of discount of $331,094                                   15,297,105
    Derivative liability                                                                210,622
    Accrued interest payable                                                            896,934
                                                                                   ------------
    Total liabilities                                                                16,664,934
                                                                                   ------------

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' DEFICIT
   Preferred stock, $.01 par value; 10,000,000 shares authorized
        Preferred stock Series A Convertible $0.01 par value;
   100,000 shares authorized, 94,443 shares issued and outstanding and no
   liquidation or redemption value                                                          944
Common stock, par value $0.001; 10,000,000,000 shares
   authorized;  12,737,983 issued and outstanding                                        12,738
   Additional paid-in capital                                                           202,697
   Retained deficit                                                                  (4,417,618)
                                                                                   ------------
   Total shareholders' deficit                                                       (4,201,239)
                                                                                   ------------
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT                                        $ 12,463,695
                                                                                   ============
</TABLE>

See accompanying Notes to the unaudited Condensed Consolidated Financial
Statements

                                        3
<PAGE>

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                      (Formerly CSI Business Finance, Inc.)
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                                 Three months ended March 31,
                                                                 ----------------------------
                                                                     2007            2006
                                                                 ------------    ------------
<S>                                                              <C>             <C>
REVENUE
   Lease income                                                  $         --    $     39,684
   Fee income                                                           2,965              --
   Trading gains (losses)                                               3,285        (133,773)
   Dividends from marketable securities                                 7,159         174,542
   Interest income from notes and debenture receivable                 74,058         143,430
                                                                 ------------    ------------
Total revenue                                                          87,467         223,883

OPERATING EXPENSES
   Selling, general and administrative expenses (2007 and 2006
      include $101,199 and $41,796, respectively of expenses
      allocated from an affiliated entity)                            374,113         276,099
Interest expense                                                      249,910         297,848
                                                                 ------------    ------------
OPERATING LOSS                                                       (536,556)       (350,064)
                                                                 ------------    ------------

OTHER (INCOME) EXPENSE
   Net change in fair value of derivative                              40,368          78,767
   Loss on extinguishment of debenture receivable                          --             639
   Interest and other income                                           (9,519)        (11,259)
                                                                 ------------    ------------
   Total other expense                                                 30,849          68,147
                                                                 ------------    ------------

   Loss before provision for income taxes                            (567,405)       (418,211)
                                                                 ------------    ------------

INCOME TAX PROVISION                                                       --              --
                                                                 ------------    ------------
NET LOSS APPLICABLE TO COMMON SHARES                             $   (567,405)   $   (418,211)
                                                                 ============    ============

   Net loss per share for basic and diluted                      $      (0.05)   $      (0.07)
                                                                 ============    ============

   Weighted shares outstanding for basic and diluted               12,579,712       6,287,660
                                                                 ============    ============
</TABLE>

See accompanying Notes to the unaudited Condensed Consolidated Financial
Statements

                                        4
<PAGE>

                    NATURAL NUTRITION, INC. AND SUBSIDIARIES
                      (Formerly CSI Business Finance, Inc.)
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                           Three Months Ended March 31,
                                                          ------------------------------
                                                              2007             2006
                                                          -------------    -------------
<S>                                                       <C>              <C>
CASH FLOWS FROM OPERATING ACTIVITIES
  Net loss                                                $    (567,405)   $    (418,211)
  Adjustment to reconcile net income to net cash
    provided by (used in) operating activities                  408,254          656,635
                                                          -------------    -------------

    Net cash provided by (used in) operating activities        (159,151)         238,424
                                                          -------------    -------------

CASH FLOWS FROM INVESTING ACTIVITIES
    Sale of asset                                               100,000               --
                                                          -------------    -------------
    Net cash provided by investing activities                   100,000               --
                                                          -------------    -------------
CASH FLOWS FROM FINANCING ACTIVITIES

    Payments on notes payable to affiliate                           --         (181,988)
                                                          -------------    -------------
    Net cash used in financing activities                            --         (181,988)
                                                          -------------    -------------
NET CHANGE IN CASH                                              (59,151)          56,436

CASH, BEGINNING OF PERIOD                                       148,691          204,243
                                                          -------------    -------------
CASH, END OF PERIOD                                       $      89,540    $     260,679
                                                          =============    =============

SUPPLEMENTAL INFORMATION

  Interest paid                                           $         710    $      51,789
                                                          =============    =============
  Taxes paid                                              $          --    $          --
                                                          =============    =============
  Exchange of certain receivable for common stock:

    Common stock acquired                                 $          --    $   9,887,959
                                                          =============    =============
    Debentures and notes receivable exchanged             $          --    $   9,609,283
                                                          =============    =============
    Accrued interest receivable exchanged                 $          --    $     278,676
                                                          =============    =============
</TABLE>

See accompanying Notes to the unaudited Condensed Consolidated Financial
Statements

                                        5
<PAGE>

                    Natural Nutrition, Inc. and Subsidiaries
                      (Formerly CSI Business Finance, Inc.)
              Notes to Condensed Consolidated Financial Statements
                                   (Unaudited)

NOTE 1 - BASIS OF PRESENTATION

Our Condensed  Consolidated  Balance  Sheet as of March 31, 2007,  the Condensed
Consolidated  Statements of Operations for the three months ended March 31, 2007
and March 31, 2006, and the Condensed Consolidated  Statements of Cash Flows for
the three months ended March 31, 2007 and March 31, 2006 have not been  audited.
These statements have been prepared on a basis that is substantially  consistent
with the accounting  principles  applied in our Annual Report on Form 10-KSB for
the fiscal  year ended  December  31,  2006.  In our  opinion,  these  financial
statements  include all normal and  recurring  adjustments  necessary for a fair
presentation of Natural  Nutrition,  Inc. (the "Company") and Subsidiaries.  The
results  for the three  months are not  necessarily  indicative  of the  results
expected for the year.

As used  herein,  the  "Company",  "management",  "we",  "our" refers to Natural
Nutrition, Inc., or Natural Nutrition, Inc. together with its subsidiaries.  The
Company's fiscal year ends on December 31st.

Certain  information  and footnote  disclosures  normally  included in financial
statements prepared in accordance with accounting  principles generally accepted
in the  United  States of  America  have been  omitted  in  accordance  with the
published rules and regulations of the U.S.  Securities and Exchange  Commission
(the  "SEC")  for  interim  financial   statements.   The  unaudited   Condensed
Consolidated Financial Statements and the notes thereto in this report should be
read in conjunction with the audited Consolidated Financial Statements and notes
thereto  included in our Annual  Report on Form 10-KSB for the fiscal year ended
December 31, 2006 (the "10-KSB").

Natural Nutrition,  Inc. (the "Company"),  formerly CSI Business Finance,  Inc.,
formerly Health Express USA, Inc., was  incorporated in Florida on July 2, 1998.
On August 25, 2005,  the Company  completed  the closing of that  certain  Share
Exchange Agreement,  by and between the Company,  CSI Business Finance,  Inc., a
Texas corporation and now wholly-owned subsidiary of the Company herein referred
to as ("CSI") and the shareholder of CSI (the "CSI Shareholder").

On August 25, 2005, the Company  effectively  exchanged with the CSI Shareholder
the issued and outstanding common stock of CSI in exchange for 100,000 shares of
Series A Convertible Preferred Stock, par value $0.01 per share, of the Company,
and CSI  became a  wholly-owned  subsidiary  of the  Company.  Each share of the
Company's  Series A  Preferred  Stock is  convertible  into 780 shares of common
stock of the Company, beginning one year after the effective date of the merger.
The  Preferred  shares were  subsequently  distributed  to the  shareholders  of
Corporate  Strategies,  Inc., the former shareholder of CSI. In addition, at the
exchange  date,  4,326,861  shares of common stock of the Company were issued to
pay off notes and debentures.  If the preferred  shareholders were to convert to
common stock as of the date of the merger, they would hold 78,000,000 shares, or
ninety-two and one half percent (92.5%) of the issued and outstanding  shares of
common  stock of the  Company.  This  conversion  would  result in the  Series A
Preferred Shareholders effectively controlling the Company.

The Series A Convertible  Preferred  Shareholders  and the holders of the common
stock  of the  Company  vote  together  and  not as  separate  classes,  and the
Preferred Stock shall be counted on an "as converted" basis,  thereby giving the
Preferred Shareholders control of the Company. The transaction was accounted for
as a reverse acquisition since control of the Company passed to the shareholders
of the acquired company (CSI).

The Company was subsequently renamed in 2005 to CSI Business Finance,  Inc. (the
Florida  corporation).  In September of 2006, CSI Business Finance, Inc. changed
its name to Natural Nutrition, Inc. and simultaneously  redomiciled from Florida
to Nevada.

On May 23, 2006, our Board of Directors approved a 1 for 25 reverse common stock
split.  All references to our common stock in this document are stated in shares
after the reverse split.

The accompanying unaudited condensed consolidated financial statements for prior
years   contain   certain   reclassifications   to  conform  with  current  year
presentation.

The unaudited condensed  consolidated  financial statements include the accounts
of the Company and its wholly-owned subsidiaries.  All significant inter-company
accounts and transactions have been eliminated in consolidation.

Change in Accounting Principle for Registration Payment Arrangements.


                                        6
<PAGE>
In December 2006, the Financial  Accounting Standards Board ("FASB") issued FASB
Staff  Position  on  No.  EITF  00-19-2,  Accounting  for  Registration  Payment
Arrangements ("FSP EITF 00-19-2"). FSP EITF 00-19-2 provides that the contingent
obligation to make future payments or otherwise transfer  consideration  under a
registration payment arrangement should be separately recognized and measured in
accordance  with  Statement of  Financial  Accounting  Standards  ("FAS") No. 5,
Accounting for Contingencies,  which provides that loss contingencies  should be
recognized as liabilities if they are probable and can be reasonably  estimated.
Subsequent  to the  adoption of FSP EITF  00-19-2,  any changes in the  carrying
amount of the  contingent  liability  will result in a gain or loss that will be
recognized in the consolidated statement of operations in the period the changes
occur.   The  guidance  in  FSP  EITF  00-19-2  is  effective   immediately  for
registration payment arrangements and the financial instruments subject to those
arrangements  that  are  entered  into or  modified  subsequent  to the  date of
issuance  of  FSP  EITF  00-19-2.  For  registration  payment  arrangements  and
financial  instruments subject to those arrangement that were entered into prior
to the  issuance  of FSP  EITF  00-19-2,  this  guidance  is  effective  for our
consolidated financial statements issued for the year beginning January 1, 2007,
and interim periods within that year.

On January 1, 2007, we adopted the provisions of FSP EITF 00-19-2 to account for
the  registration  payment  arrangement   associated  with  our  September  2005
financing (the "September 2005 Registration Payment Arrangement"). As of January
1, 2007 and March 31, 2007,  management determined that is was not probable that
we would have any  payment  obligation  under the  September  2005  Registration
Payment Arrangement; therefore, no accrual for contingent obligation is required
under the provisions of FSP EITF 00-19-2. Accordingly, the comparative condensed
consolidated  financial  statements of prior periods have been adjusted to apply
the new method retrospectively. The following financial statement line items for
the three  months  ended March 31, 2007 and 2006 were  affected by the change in
accounting principle:

                                        7
<PAGE>

Consolidated Statements of Operations

<TABLE>
<CAPTION>

                                              As Computed      As Reported
                                                  under          under FSP        Effect of
                                               EITF 00-19      EITF 00-19-2        Change
                                              -------------    -------------    -------------
<S>                                           <C>              <C>              <C>

Three months ended March 31, 2007
Loss from operations                          $    (561,203)   $    (536,556)   $     (24,647)
Net change in fair value of derivative               40,368           40,368               --
Net loss                                           (592,052)        (567,405)         (24,647)
Net loss per share                                    (0.05)           (0.05)           (0.00)

Three months ended March 31, 2006
Loss from operations                               (374,464)        (350,064)         (24,400)
Net change in fair value of derivative               17,258           78,767           61,509
Net loss                                           (381,102)        (418,211)          37,109
Net loss per share                                    (0.06)           (0.07)            0.01


Consolidated Balance Sheet

March 31, 2007
Debenture payable - net of discount           $  15,126,529    $  15,297,105    $     170,576
Derivative liability                                381,198          210,622         (170,576)
Total liabilities and shareholders' deficit      12,463,695       12,463,695               --


Consolidated Statements of Cash Flows

March 31, 2007
Net loss                                      $    (592,052)   $    (567,405)   $      24,647
Net change in fair value of derivatives and
  amortization of debt discount                      74,311           49,664          (24,647)

March 31, 2006
Net loss                                           (381,102)        (418,211)          37,109
Net change in fair value of derivatives and
  amortization of debt discount                      51,004           88,113          (37,109)

</TABLE>

                                        8
<PAGE>

NOTE 2. INCOME (LOSS) PER COMMON SHARE AND STOCK BASED COMPENSATION

Net Income (Loss) Per Common Share

In accordance with SFAS No. 128, "Earnings per Share",  basic earnings per share
are computed based on the weighted  average  shares of common stock  outstanding
during  the  periods.  Diluted  earnings  per  share are  computed  based on the
weighted  average  shares of common  stock plus the  assumed  issuance of common
stock for all potentially dilutive securities.

Our basic and diluted  shares used to compute loss per common share  amounts are
the same for both the three  months  ended  March 31,  2007 and March 31,  2006.
Since we had a net loss for the three  months ended March 31, 2007 and March 31,
2006,  the assumed  exercise of stock options and the conversion of the Series A
Preferred Stock and secured convertible  debentures  outstanding as of March 31,
2007 and March 31, 2006 would be anti-dilutive.

Stock Based Compensation

Statement  of  Financial  Accounting  Standards  No.  123(R),   "Accounting  for
Stock-Based  Compensation"  ("SFAS  123(R)"),  provides  for  the  use of a fair
value-based  method of accounting  for employee  stock  compensation.  There are
outstanding  stock options to purchase 5,695 of the Company's common stock at an
exercise  price of $32.75 per share.  These  options  expire in August 2007.  We
believe  these  options do not have a fair market value and we expect them to be
forfeited.

NOTE 3 - AGREEMENT IN LIEU OF FORECLOSURE

On September 5, 2005,  CSI Business  Finance,  Inc purchased the senior  secured
debt of Bio One Corporation for $9,600,000.  The Company  originally  planned to
profit from this transaction  based on its ability to convert the debt purchased
into Bio One common  stock at a twenty  percent  discount to the market price of
the Bio One common stock.  However,  Bio One common stock  stopped  trading some
time after the note purchase was complete,  and CSI Business Finance, Inc had to
look to the assets underlying the note purchased for repayment as Bio One was no
longer  a viable  enterprise.  On March  22,  2006,  the  Company  completed  an
agreement in lieu of  foreclosure  (the  "Agreement")  with Bio One  Corporation
("Bio-One") and received the stock of Interactive Nutrition International,  Inc.
("INII"),  along with other assets and claims,  in return for the forgiveness of
$9,887,959 in debt and accrued interest of Bio-One which is now being treated as
an   investment    in   INII.    INII   is   currently    being    operated   by
PriceWaterhouseCoopers  ("PWC") as  Receiver  and  Manager  pursuant  to Section
246(2) of the Bankruptcy and Insolvency Act of Canada,  after being requested to
do so by Nesracorp Inc., Eli Nesrallah,  Joseph  Nesrallah and Pamela  Nesrallah
(collectively,  the  "Sellers"),  purporting  default in payment of  obligations
incurred in the purchase of INII assets by Bio-One. A  Court-supervised  sale of
the assets has been  requested by the Receiver,  and the Company has  vigorously
opposed  this  and  pursued   numerous   damage  claims   against  the  Sellers.
Additionally,  the Company has been  assigned  all rights and claims  previously
asserted against the Sellers, Roxanne Anderson and PWC filed by INII and Bio-One
in the  Ontario  Superior  Court of Justice on January  13,  2005.  The  Company
intends to pursue  some or all of the  previous  claims in the filing of January
13, 2005 in Ontario  Superior  Court of Justice,  as the stock of INII and these
claims,  as well as others,  have been  assigned  to the  Company as part of the
Agreement the Company executed with Bio-One on March 22, 2006.

On May 5, 2006, the Board of Directors terminated the Nesrallahs as employees of
the Company.  On March 30, 2006,  the Company  filed a lawsuit in State Court in
Orlando, Florida against the Nesrallahs, alleging, among other claims, breach of
fiduciary  duty to INII. As of the date of this filing,  the Florida  action has
been  abated  pending the  outcome of the  results of our  agreement  in lieu of
foreclosure  disclosed  in our  Current  Report on Form 8-K filed on January 12,
2007. On March 31, 2007,  management  was  successful in extending the letter of
intent to May 4, 2007. As of the date of this filing,  the agreement has expired
in accordance with its terms. Management is attempting to obtain an extension of
the expired  agreement,  but there can be no assurances that this will occur. No
reserve  has been  established  for a loss on this  transaction,  as the Company
believes  its  claims  are  meritorious  and have a  reasonable  probability  of
prevailing  in a  Court  of  law,  or of  entering  into  a  mutually  agreeable
settlement. We have reduced our investment by $350,000 in 2006 and an additional
$100,000 in the first  quarter of 2007 for  proceeds  from the sale of an asset.
However,  should the  Company  fail to prevail or settle its claims  against the
Seller's,  the Company will be required to write down its entire  investment  of
$9,437,959 in INII.  Shareholders are cautioned that the loss of this investment
could  result in the  complete  failure of the  Company and  foreclosure  of its
remaining assets by its lender.

NOTE 4 - CONVERTIBLE DEBENTURES PAYABLE AND DERIVATIVE FINANCIAL INSTRUMENTS

Effective September 9, 2005, the Company issued a secured convertible  debenture
(the "Debenture") to Cornell Capital Partners,  LP in the amount of $15,635,199.
The notes bear interest at 5%, which is accrued  until  maturity on September 8,
2008. The note is convertible,  at the option of the holders,  into common stock
of the Company at a price of $0.09 per share, subject to standard  anti-dilution
provisions  relating to splits,  reverse  splits and other  transactions  plus a
reset  provision  whereby the  conversion  prices may be adjusted  downward to a
lower price per share based on the average of the three  lowest  closing  prices
for the five trading days prior to conversion. The Holder has the right to cause
the notes to be converted into common stock,  subject to an ownership limitation
of 4.99% of the outstanding  stock.  The Company has the right to repurchase the
Notes at 106% of the face amount.

The derivatives from the debenture  payable has been accounted for in accordance
with  SFAS  133  and  EITF  No.  00-19,  "Accounting  for  Derivative  Financial
Instruments Indexed to, and Potentially Settled in, a Company's Own Stock."

                                        9
<PAGE>

The  Company  has  determined  that the  following  instrument  has  derivatives
requiring  evaluation and accounting under the relevant  guidance  applicable to
financial derivatives:

      o     Cornell  Debenture  Payable  issued  9/9/05  in the face  amount  of
            $15,635,199

The Company has identified  that the above  debenture has embedded  derivatives.
These embedded  derivatives have been bifurcated from their respective host debt
contracts and accounted for as derivative  liabilities  in accordance  with EITF
00-19. When multiple derivatives exist within the Convertible  Debentures,  they
have been bundled together as a single hybrid compound  instrument in accordance
with SFAS No. 133  Derivatives  Implementation  Group  Implementation  Issue No.
B-15,  "Embedded  Derivatives:   Separate  Accounting  for  Multiple  Derivative
Features Embedded in a Single Hybrid Instrument."

The embedded  derivatives within the Convertible  Debenture has been recorded at
fair value at the date of  issuance;  and are  marked-to-market  each  reporting
period with changes in fair value recorded to the Company's  income statement as
"Net change in fair value of  derivatives."  The  Company  has  utilized a third
party  valuation  firm to fair value the  embedded  derivatives  using a layered
discounted  probability-weighted  cash  flow  approach.  The  fair  value  model
utilized to value the various embedded derivatives in the Convertible Debenture,
comprises  multiple  probability-weighted  scenarios  under various  assumptions
reflecting  the economics of the  Convertible  Debenture,  such as the risk-free
interest  rate,  expected  Issuer  stock  price and  volatility,  likelihood  of
conversion and or redemption, and likelihood default status.

The fair value of the derivative  liabilities  are subject to the changes in the
trading value of the  Company's  common stock,  as well as other  factors.  As a
result, the Company's financial statements may fluctuate from quarter-to-quarter
based on factors,  such as the price of the Company's stock at the balance sheet
date and the amount of shares converted by the debenture holders.  Consequently,
our   financial   position   and   results   of   operations   may   vary   from
quarter-to-quarter  based on conditions  other than our  operating  revenues and
expenses.

The  conversion  feature,  reset  provision  and the  Company's  optional  early
redemption right to the debenture payable have been bundled together as a single
compound  embedded  derivative   liability,   and  using  a  layered  discounted
probability-weighted  cash flow approach,  was initially fair valued at $413,603
at September 9, 2005. Using the same  methodology,  the single compound embedded
derivative  liability  was valued at $210,622 at March 31, 2007.  For the period
since  December 31, 2006 through March 31, 2007, the change in fair value of the
derivative liability was a decrease of $40,368, which has been classified as net
change in fair value of derivative.

The above compound  embedded  derivative  plus the loan costs paid the lender in
the amount of $687,832 are recorded as a discount against the notional  carrying
amount of the debenture  payable.  The  unamortized  discount is being amortized
over the term of the note  using the  effective  interest  method.  Recorded  in
interest expense for this  amortization is $56,524 at March 31, 2007 and $53,295
at March 31, 2006.

ITEM 2 .      MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

FORWARD-LOOKING STATEMENTS AND ASSOCIATED RISKS

This  Quarterly  Report on Form  10-QSB,  and the  accompanying  MD&A,  contains
forward-looking  statements.  Statements  contained in this report about Natural
Nutrition,  Inc.'s future outlook,  prospects,  strategies and plans,  and about
industry  conditions and demand for our financial services are  forward-looking.
All statements that express  belief,  expectation,  estimates or intentions,  as
well as those that are not statements of historical  fact, are forward  looking.
The words "proposed,"  "anticipates,"  "anticipated," "will," "would," "should,"
"estimates"  and similar  expressions  are intended to identify  forward-looking
statements.  Forward-looking  statements represent our reasonable belief and are
based on our current expectations and assumptions with respect to future events.
While we believe our expectations  and assumptions are reasonable,  they involve
risks and  uncertainties  beyond our control that could cause the actual results
or outcome to differ  materially from the expected results or outcome  reflected
in our forward-looking  statements.  In light of these risks,  uncertainties and
assumptions,  the forward-looking  events discussed in this quarterly report may
not  occur.  Such  risks and  uncertainties  include,  without  limitation,  our
successful efforts in the outcome of our litigation concerning our investment in
INII, or the extension of our agreement in lieu of  foreclosure,  our success in
trading  marketable  securities,  our  ability to  maintain  contracts  that are
critical to our operations, actual customer demand for our financing and related
services, collection of accounts and notes receivable, our ability to obtain and
maintain  normal terms with our vendors and service  providers and conditions in
the  capital  markets  and  equity  markets  during the  periods  covered by the
forward-looking statements.

                                       10
<PAGE>

The  forward-looking  statements  contained  in this report speak only as of the
date  hereof.  We  undertake  no  obligation  to  publicly  update or revise any
forward-looking  statements,  whether  as a result  of new  information,  future
events or any other  reason.  All  forward-looking  statements  attributable  to
Natural  Nutrition,  Inc.  or any  person  acting on its  behalf  are  expressly
qualified in their entirety by the cautionary  statements  contained or referred
to in our annual report filed on Form 10-KSB and in our future periodic  reports
filed with the SEC. The following M,D&A should be read in conjunction with these
unaudited Condensed  Consolidated  Financial  Statements of the Company, and the
related notes thereto  included  elsewhere  herein,  and in conjunction with our
audited financial statements, together with footnotes and the M,D&A, in our 2006
annual report filed on Form 10-KSB with the Securities  Exchange Commission (the
"SEC").

Overview

On August 25, 2005,  Health  Express USA, Inc., a Florida  corporation,  entered
into a share  exchange  agreement  with  CSI  Business  Finance,  Inc.,  a Texas
corporation ("CSI") and the shareholder of CSI (Corporate Strategies, Inc.). The
transaction  is being  reflected as a reverse  acquisition  since control of the
Company has passed to the shareholders of Corporate Strategies, Inc. ("Corporate
Strategies").  The  Company  was  subsequently  renamed in 2005 to CSI  Business
Finance,  Inc.  (the  Florida  corporation).  In  September of 2006 CSI Business
Finance,  Inc. changed its name to Natural  Nutrition,  Inc. and  simultaneously
redomiciled from Florida to Nevada.

On May 23, 2006, our Board of Directors approved a 1 for 25 reverse split of our
common stock.  All references to our common stock in this document are stated in
shares after the reverse split.

Since CSI is the surviving entity of the reverse merger,  the financial  reports
include the operating results of CSI for the entire year 2005 and the results of
operations  for the period  August 25, 2005  through  December  31, 2005 for the
Company.  The March 31, 2006 financial  statements of the Company  represent the
condensed  consolidated  results  of  operations  for the  entire  quarter.  All
significant  intercompany  accounts and  transactions  have been  eliminated  in
consolidation.

At present our Company,  through our operating  subsidiary,  primarily generates
cash  and  revenue  from  financing  and  investing  activities.  To date  these
activities have included equipment leasing, factoring, loan brokerage activities
earned in originating and selling business leases,  providing short term secured
lending, and investing in marketable securities. Competition for the services we
provide  comes  mainly  from  financial   institutions  that  provide  factoring
services,  equipment  leases  and  small  business  loans,  many of  which  have
substantially more capital resources than our Company.

We also actively trade  marketable  securities and options with available  cash,
and on margin,  through a third party  investment  advisor.  Because our trading
involves leveraging, these transactions contain a considerable amount of risk.

Management of the Company  mitigates its risk in lending by securing  loans with
pledged assets (collateral) that, when liquidated, have a reasonable probability
of realizing  proceeds that would retire the liability.  In some  instances,  we
obtain personal  guarantees from  individuals of net worth which are adequate to
repay the  liability  in the event of default.  Additionally,  in the example of
public company finance, we utilize conversion features at a substantial discount
to the market in the event of default that would  enable us to realize  adequate
proceeds  from the sale of the  borrower's  stock to repay the  liability to the
Company. Over the long term, management would like to concentrate its efforts on
growing the business of INII, our largest asset.

On September 5, 2005,  CSI Business  Finance,  Inc purchased the senior  secured
debt of Bio One Corporation for $9,600,000.  The Company  originally  planned to
profit from this transaction  based on its ability to convert the debt purchased
into Bio One common  stock at a twenty  percent  discount to the market price of
the Bio One common stock.  However,  Bio One common stock  stopped  trading some
time after the note purchase was complete,  and CSI Business Finance, Inc had to
look to the assets underlying the note purchased for repayment as Bio One was no
longer  a viable  enterprise.  On March  22,  2006,  the  Company  completed  an
agreement in lieu of  foreclosure  (the  "Agreement")  with Bio One  Corporation
("Bio-One") and received the stock of INII,  along with other assets and claims,
in return for the  forgiveness  of  $9,887,959  in debt and accrued  interest of
Bio-One which is now being  treated as an investment in INII.  INII is currently
being  operated  by  PriceWaterhouseCoopers  ("PWC")  as  Receiver  and  Manager
pursuant to Section 246(2) of the Bankruptcy and Insolvency Act of Canada, after
being requested to do so by Nesracorp Inc., Eli Nesrallah,  Joseph Nesrallah and
Pamela Nesrallah (collectively, the "Sellers"), purporting default in payment of
obligations   incurred  in  the   purchase   of  INII   assets  by  Bio-One.   A
Court-supervised sale of the assets has been requested by the Receiver,  and the
Company has vigorously  opposed this and pursued  numerous damage claims against
the Sellers.  Additionally,  the Company has been assigned all rights and claims
previously asserted against the Sellers,  Roxanne Anderson and PWC filed by INII
and Bio-One in the Ontario  Superior  Court of Justice on January 13, 2005.  The
Company  intends to pursue some or all of the  previous  claims in the filing of
January 13, 2005 in Ontario Superior Court of Justice,  as the stock of INII and
these  claims,  as well as others,  have been assigned to the Company as part of
the Agreement the Company executed with Bio-One on March 22, 2006.

On May 5, 2006, the Board of Directors terminated the Nesrallahs as employees of
the Company.  On March 30, 2006,  the Company  filed a lawsuit in State Court in
Orlando, Florida against the Nesrallahs, alleging, among other claims, breach of
fiduciary  duty to INII. As of the date of this filing,  the Florida  action has
been  abated  pending the  outcome of the  results of our  agreement  in lieu of
foreclosure  disclosed  in our  Current  Report on Form 8-K filed on January 12,
2007. On March 31, 2007,  management  was  successful in extending the letter of
intent to May 4, 2007. As of the date of this filing,  the agreement has expired
in accordance with its terms.

                                       11
<PAGE>

Management is attempting  to obtain an extension of the expired  agreement,  but
there can be no assurances that this will occur. No reserve has been established
for a loss  on  this  transaction,  as  the  Company  believes  its  claims  are
meritorious  and have a reasonable  probability of prevailing in a Court of law,
or of  entering  into a  mutually  agreeable  settlement.  We have  reduced  our
investment by $350,000 in 2006 and an  additional  $100,000 in the first quarter
of 2007 for proceeds from the sale of an asset. However, should the Company fail
to prevail or settle  its claims  against  the  Seller's,  the  Company  will be
required to write down its entire investment of $9,437,959 in INII. Shareholders
are  cautioned  that the loss of this  investment  could  result in the complete
failure of the Company and foreclosure of its remaining assets by its lender.

As a result of the above  foreclosure,  the  Company has  recorded a  $9,887,959
investment in the INII stock consisting of an $8,500,000  debenture  receivable,
$1,109,283 notes receivable and $278,676 of accrued interest receivable. We have
reduced our investment by $450,000 for proceeds from the sale of an asset.

Recent Accounting Pronouncements

In February 2007, the FASB issued FASB Statement No. 159,  Establishing the Fair
Value Option for Financial  Assets and Liabilities  ("SFAS 159") , to permit all
entities to choose to elect to measure  eligible  financial  instruments at fair
value.  SFAS 159 applies to fiscal years beginning after November 15, 2007, with
early  adoption  permitted  for an  entity  that has also  elected  to apply the
provisions of SFAS 157, Fair Value  Measurements . An entity is prohibited  from
retrospectively applying SFAS 159, unless it chooses early adoption.  Management
is currently  evaluating  the impact of SFAS 159 on the  consolidated  financial
statements.

RESULTS OF OPERATIONS

Three Months Ended March 31, 2007 and March 31, 2006

We had no leasing  income for the three months ended March 31, 2007 (the "1Q '07
Period").  Leasing income for the three months ended March 31, 2006 (the "1Q '06
Period") was  $39,684.  We may  continue to seek  leasing  opportunities  in the
future,  however, this is not the primary focus of management,  or the Company's
resources.  Fee income from  brokerage  fees earned in  originating  and selling
business  leases and loans was $2,965 for the 1Q '07 Period versus $0 for the 1Q
'06 Period.

Interest Income was $74,058 for the 1Q `07 Period as compared to $143,430 in the
1Q `06 Period. Interest income was derived mainly from notes receivable relating
to  receivables  factoring and  investments as well as interest from a debenture
and  notes  that  were  subsequently  traded  on March  22,  2006 for stock in a
Canadian  subsidiary of the maker of the debentures.  Dividend income was $7,159
for the 1Q `07 Period and  $174,542  for the 1Q `06 Period.  Dividend  income is
primarily derived from various investments in marketable securities.  For the 1Q
`07 Period, we recorded net trading gains from various investments in marketable
securities in the amount of $3,285.  Of the gains for the 1Q '07 Period,  $1,453
were realized trading losses while $4,738 were unrealized trading gains. For the
1Q `06 Period, we recorded $133,773 in net trading losses,  $464,674 in realized
trading  losses and $330,901 in  unrealized  trading  gains.  We actively  trade
marketable securities and consider trading to be a source of future revenue. The
Company has taken steps to protect  its  portfolio  with the use of put and call
options  to limit the risk of  losses in the  future,  while  maximizing  upside
potential.

We have not yet reached the size to benefit  from  separate  office  space and a
dedicated  staff.  Our Company  shares  office space and certain  administrative
functions  and staff with an affiliated  company.  Costs are allocated for these
shared functions are based on an estimate of time usage.

Our  operating  expenses  were  $624,023  for the 1Q `07 Period as  compared  to
$573,947 for the 1Q `06 Period.

 Salaries and Benefits were  $106,538 for the 1Q '07 Period  versus  $83,561 for
the 1Q `06 Period.  The primary reason for the increase was the hiring of a part
time CFO in the third  quarter  of our  calendar  year 2006,  a new  transaction
principal  in January of 2007 and an  increase  in salary to our CEO and another
employee, less salaries allocated in prior quarters.

Professional  fees were $60,764 in the 1Q `07 Period as compared to $151,737 for
the 1Q `06 Period.  The  difference is primarily a result of legal fees incurred
for our INII litigation in the first quarter of 2006.

Interest  expense was $249,910 for the 1Q '07 Period and $297,848 for the 1Q `06
Period.  Interest expense primarily  relates to the expense  associated with the
$15,635,199  five percent (5%) convertible  debenture  entered into in September
2005 to fund INII and interest on our margin loan.

The Company was  allocated  overhead from an affiliate in the amount of $101,199
for the 1Q `07 Period as compared to $41,796 for the 1Q `06 Period. The increase
in the  overhead  allocation  is  primarily  due to the amount of due  diligence
expended on the INII transaction  from members of our affiliate.  No contractual
arrangement exists between the two companies.

                                       12
<PAGE>

Liquidity and Capital Resources

Operating Activities

We incurred a net loss for the three  months  ended March 31, 2007 in the amount
of $567,405.  During the three months ended March 31, 2007, our operations  used
cash  flow in the  amount  of  $159,151.  Our uses in  operating  cash  flow was
primarily by an increase in notes  receivable  ($178,921) an increase in amounts
due from  affiliates  ($29,167) and an increase in prepaid  expenses  ($50,730).
Cash flow from operating  activities was generated  primarily from a decrease in
the value of our investments in marketable securities ($391,855) and an increase
in accrued liabilities ($144,263).

Investing Activities

We realized $100,000 in proceeds from the sale of assets. The asset was included
as a part of our  investment  in  INII.  A  receivable  for this  asset  was not
recorded when our original  investment  in INII was made.  The proceeds from the
collection of this loan were charged to our investment in INII.

Financing Activities

For the three  months  ended  March 31,  2007,  there  were no cash  flows  from
financing activities.

The Company had working  capital in the amount of  $2,736,172 at March 31, 2007.
Included in our working capital is $1,978,142 of short term notes receivable and
$702,782 in  investments  in marketable  securities.  For the three months ended
March 31, 2007 we made $175,000 of loans to two new clients.

Our cash flows for the periods are summarized below:

<TABLE>
<CAPTION>

                                            Three Months Ended    Three Months Ended
                                              March 31, 2007        March 31, 2006
                                            ------------------    ------------------
<S>                                         <C>                   <C>

Net cash provided (used) in
operating activities                        $         (159,151)   $          238,424

Net cash provided by investing activities   $          100,000    $                0
Net cash used in financing activities       $                0    $         (181,988)

</TABLE>

Our cash decreased $59,151 since December 31, 2006.

Management  believes  the Company has  adequate  working  capital and cash to be
provided from  operating  activities to fund current  levels of  operations.  We
anticipate  that our company will grow. As our business grows we believe that we
will have to raise  additional  capital in the  private  debt and public  equity
markets to fund our investments.

Off-Balance Sheet Arrangements

The Company had no off-balance  sheet  arrangements or guarantees of third party
obligations at March 31, 2007.

Inflation

The  Company  believes  that  inflation  has not  had a  significant  impact  on
operations since inception.

ITEM 3. CONTROLS AND PROCEDURES

(A) Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures designed to ensure that
information  required to be  disclosed  in reports  filed  under the  Securities
Exchange  Act  of  1934,  as  amended,  is  recorded,   processed,   summarized,
accumulated and  communicated to the Company's  management,  including its Chief
Executive Officer ("CEO") and Chief Financial  Officer ("CFO"),  as appropriate,
to allow timely decisions  regarding required  disclosure.

As of the end of the period  covered by this report,  the  Company's  management
carried out an evaluation,  under the supervision and with the  participation of
the  Company's  Chief  Executive  Officer  ("CEO") and Chief  Financial  Officer
("CFO"),  of the  effectiveness  of the design and  operation  of the  Company's
system of disclosure  controls and  procedures  pursuant to the  Securities  and
Exchange Act, Rule 13a-15(e) and 15d-15(e) under the Exchange Act). Based on the
material  weaknesses  described  herein the Company's CEO and CFO have concluded
that the Company's disclosure controls and procedures were not effective,  as of
the  date of  that  evaluation,  for  the  purposes  of  recording,  processing,
summarizing  and  timely  reporting  of  material  information  required  to  be
disclosed in reports filed by the Company under the Exchange Act. Because of our
size, the Company shares its accounting staff with an affiliated  company and is
comprised of its part-time  Chief Financial  Officer,  controller and data entry
clerk.  The controller and data entry clerk are  considered  contract  employees
whom also work for an affiliated company as contract employees.  Our CFO is also
an employee of an affiliate.  Because of the  structure of our staff,  we have a
failure to maintain  effective  controls  over the  selection,  application  and
monitoring  of our  accounting  policies to assure that certain  complex  equity
transactions were accounted for in accordance with generally accepted accounting
principles.

                                       13
<PAGE>

(B) Changes in Internal Controls over Financial Reporting

In connection with the evaluation of the Company's  internal controls during the
Company's last fiscal quarter covered by this report,  the Company's CEO and CFO
have  determined that there were no changes to the Company's  internal  controls
over financial reporting that have materially affected, or are reasonably likely
to materially effect, the Company's internal controls over financial reporting.

Material Weaknesses Identified

In connection with the audit of our  consolidated  financial  statements for the
fiscal  year  ended  December  31,  2006,  our  independent   registered  public
accounting firm informed us that we have significant  deficiencies  constituting
material weaknesses. As defined by the Public Company Accounting Oversight Board
Auditing Standard No. 2, a material weakness is a significant control deficiency
or a combination of significant control  deficiencies that result in there being
more than a remote  likelihood  that a  material  misstatement  in the annual or
interim  financial  statements  will not be prevented or detected.  The material
weaknesses identified by the auditor during the December 31, 2005 and 2006 audit
were the lack of segregation of duties  necessary to maintain  proper checks and
balances  between  functions and the lack of procedures to properly  account for
non-routine   transactions  and  preparation  of  certain  financial   statement
disclosures  in accordance  with U.S.  GAAP.  The absence of qualified full time
accounting personnel was a contributing factor to the problems identified by the
auditor.  The  specific  circumstances  giving  rise to the  weaknesses  include
utilizing  the  services  of  contract  accountants  on a part time basis in the
absence of internal accounting personnel.

Further,  based on the material  weaknesses  described herein, we concluded that
our disclosure controls and procedures were not effective at March 31, 2007, the
end of this reporting period..

Remediation Plan regarding the Material Weaknesses

The  Company has taken the  following  steps to address  the  specific  problems
identified by the auditors:

      (1)   Our affiliate has hired of a Chief Financial  Officer and a contract
            part-time   bookkeeper  to  allow  us  to  properly   implement  the
            segregation  of duties  necessary  to maintain  checks and  balances
            between accounting and Executive functions.

      (2)   All non-routine transactions will be reviewed by our Chief Financial
            Officer and, contract controller before they are completed.

      (3)   The Company will emphasize  enhancement of the segregation of duties
            based  on  the  limited   resources  the  Company  has,  and,  where
            practical,  the  Company  will  continue  to access the cost  versus
            benefit  of adding  additional  resources  that would  mitigate  the
            situation.  Our Chief Financial  Officer will monitor our accounting
            policies to assure proper  accounting for financial  derivatives and
            other unusual transactions on an ongoing basis.

The Company  continues its efforts to remediate  control  weaknesses and further
improve and strengthen its internal  control over financial  reporting under the
direction of the CEO and the CFO.

                                       14

<PAGE>

                           PART II - OTHER INFORMATION

ITEM 1 . LEGAL PROCEEDINGS

On September 5, 2005,  CSI Business  Finance,  Inc purchased the senior  secured
debt of Bio One Corporation for $9,600,000.  The Company  originally  planned to
profit from this transaction  based on its ability to convert the debt purchased
into Bio One common  stock at a twenty  percent  discount to the market price of
the Bio One common stock.  However,  Bio One common stock  stopped  trading some
time after the note purchase was complete,  and CSI Business Finance, Inc had to
look to the assets underlying the note purchased for repayment as Bio One was no
longer  a viable  enterprise.  On March  22,  2006,  the  Company  completed  an
agreement in lieu of  foreclosure  (the  "Agreement")  with Bio One  Corporation
("Bio-One") and received the stock of INII,  along with other assets and claims,
in return for the  forgiveness  of  $9,887,959  in debt and accrued  interest of
Bio-One which is now being  treated as an investment in INII.  INII is currently
being  operated  by  PriceWaterhouseCoopers  ("PWC")  as  Receiver  and  Manager
pursuant to Section 246(2) of the Bankruptcy and Insolvency Act of Canada, after
being requested to do so by Nesracorp Inc., Eli Nesrallah,  Joseph Nesrallah and
Pamela Nesrallah (collectively, the "Sellers"), purporting default in payment of
obligations   incurred  in  the   purchase   of  INII   assets  by  Bio-One.   A
Court-supervised sale of the assets has been requested by the Receiver,  and the
Company has vigorously  opposed this and pursued  numerous damage claims against
the Sellers.  Additionally,  the Company has been assigned all rights and claims
previously asserted against the Sellers,  Roxanne Anderson and PWC filed by INII
and Bio-One in the Ontario  Superior  Court of Justice on January 13, 2005.  The
Company  intends to pursue some or all of the  previous  claims in the filing of
January 13, 2005 in Ontario Superior Court of Justice,  as the stock of INII and
these  claims,  as well as others,  have been assigned to the Company as part of
the Agreement the Company executed with Bio-One on March 22, 2006.

On May 5, 2006, the Board of Directors terminated the Nesrallahs as employees of
the Company.  On March 30, 2006,  the Company  filed a lawsuit in State Court in
Orlando, Florida against the Nesrallahs, alleging, among other claims, breach of
fiduciary  duty to INII. As of the date of this filing,  the Florida  action has
been  abated  pending the  outcome of the  results of our  agreement  in lieu of
foreclosure  disclosed  in our  Current  Report on Form 8-K filed on January 12,
2007. On March 31, 2007,  management  was  successful in extending the letter of
intent to May 4, 2007. As of the date of this filing,  the agreement has expired
in accordance with its terms. Management is attempting to obtain an extension of
the expired  agreement,  but there can be no assurances that this will occur. No
reserve  has been  established  for a loss on this  transaction,  as the Company
believes  its  claims  are  meritorious  and have a  reasonable  probability  of
prevailing  in a  Court  of  law,  or of  entering  into  a  mutually  agreeable
settlement. We have reduced our investment by $350,000 in 2006 and an additional
$100,000 in the first  quarter of 2007 for  proceeds  from the sale of an asset.
However,  should the  Company  fail to prevail or settle its claims  against the
Seller's,  the Company will be required to write down its entire  investment  of
$9,437,959 in INII.  Shareholders are cautioned that the loss of this investment
could  result in the  complete  failure of the  Company and  foreclosure  of its
remaining assets by its lender.

The  Company  from time to time may be involved in various  other  lawsuits  and
actions by third  parties  arising in the ordinary  course of  business.  Unless
noted  elsewhere  in this  filing,  management  is not  aware of any  additional
pending  litigation,  claims or assessments  that could have a material  adverse
effect on the Company's business, financial condition and results of operations.


ITEM 2 . UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3 . DEFAULTS UPON SENIOR SECURITIES

None.


ITEM 4 . SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

ITEM 5 . OTHER INFORMATION

None.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (A)  Documents  filed as a part of this
report.

EXHIBIT 31.1 Officer's Certification Pursuant to Section 302

EXHIBIT 32.1 Certificate  pursuant to 18 U.S.C. Section 1350 as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002

(B) Current Reports filed on Form 8-K:

Item 7.01  Regulation FD disclosure as filed on January 12, 2007 an incorporated
herein by reference.

                                       15


<PAGE>

                                   SIGNATURES

In accordance with the  requirements of the Exchange Act, the Company has caused
this  Quarterly  Report  on Form  10-QSB/A  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

 Date: May 14, 2007                      Natural Nutrition, Inc.
                                   (Formerly CSI Business Finance, Inc.)
                            ----------------------------------------------------
                                               (Registrant)

                                          /s/ Timothy J Connolly
                            ----------------------------------------------------
                                           Timothy J. Connolly
                                         Chief Executive Officer

                            ----------------------------------------------------

 Date: May 14, 2007                      Natural Nutrition, Inc.
                                   (Formerly CSI Business Finance, Inc.)
                            ----------------------------------------------------
                                               (Registrant)

                                           /s/ Wm Chris Mathers
                            ----------------------------------------------------
                                             Wm Chris Mathers
                                         Chief Financial Officer

                            ----------------------------------------------------

                                       16